Drugs / Toludivenlafaxine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05905120 | Mar → Jun 2023 | major depressive disorder | Shanghai Mental Health Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Toludivenlafaxine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05905120 ↗ |
| Route | Oral | “orally at 30 min after the start of meals” NCT05905120 ↗ |